Moderna, Inc. 8K

Moderna appointed former Biogen CFO Michael McDonnell to its Board of Directors and Audit Committee effective July 8, 2026.

On July 8, 2026, Moderna, Inc. announced that it has appointed Michael McDonnell, the former Executive Vice President and Chief Financial Officer of Biogen Inc., to its Board of Directors effective the same day, and that he will also serve on the Board’s Audit Committee, bringing more than 35 years of financial leadership and public company experience to support Moderna’s pipeline advancement, anticipated multiple product launches, and long-term strategic execution.

Filing Facts

CIK

1682852

Ticker

MRNA

Form

8K

Source Type

fda

Accession

0001682852-26-000134

Alert Tier

5